Unstructured Data

Transform Rich Clinical Notes Into Integrated Insights

MMIT and its parent company Norstella transform physician clinical notes, specialty consultations and other unstructured EMR notes into longitudinal, analytic-ready data.

Learn More


Physician Sentiment

Understand HCPs’ ordering and prescribing behavior and the sentiment behind it.

Disease Profiling

Go beyond the diagnosis to understand disease progression through data such as tumor stage/sizing and histology.

Treatment History

Uncover hard-to-find information such as dose frequency, treatment duration and reasons for switching.

Patient Journey

Correlate treatment patterns with HCP sentiment and behavior, payer coverage, site-of-care trends and other factors.

Features

What Makes Us Different?

Data

Technology

People

Our clinical, technology, data and pharmacy experts form a cross-functional team to review and validate every AI-generated output to ensure quality, accuracy, and trust.

Increase Efficiency

Increase rebate processing team efficiency.

Reduce Leakage

Reduce rebate leakage and protect millions of dollars from leaving your organization due to incorrect formulary and medical benefit positioning.

Features

USE CASE

Transform Patient Care With Integrated Lab and EMR Data

Revolutionize patient care by combining structured lab data with unstructured EMR notes.

Lab Data

  1. Identifies patient with specific biomarkers
  2. Enables precision medicine and targeted therapy
plus-sign

Enhanced Insights With EMR Notes

  1. Tracks tumor sizing trends over time
  2. Reveals when to switch therapies
  3. Provides actionable insights for timely interventions
equals

This integration empowers HCPs to make proactive, informed decisions – positioning your product where it matters most and improving patient outcomes.

Lab Data

  1. Identifies patient with specific biomarkers
  2. Enables precision medicine and targeted therapy
plus-sign

Enhanced Insights With EMR Notes

  1. Tracks tumor sizing trends over time
  2. Reveals when to switch therapies
  3. Provides actionable insights for timely interventions
equals

This integration empowers HCPs to make proactive, informed decisions – positioning your product where it matters most and improving patient outcomes.

Slide 3

WHATS NEW

Keep Up-to-Date With Key Insights From MMIT

norstellalinq

NorstellaLinQ

The biopharma industry’s first fully integrated data asset is paving the way for breakthroughs in commercialization.

unlocking-value-potential-for-a-clients-rare-disease-treatment

Unlocking Value Potential for a Client’s Rare Disease Treatment

Learn how MMIT, powered by NorstellaLinQ, translated complex real-world data into actionable strategies to help a pharmaceutical manufacturer identify patients early in the treatment journey for a rare disease.

complex-cohort-identification-fuels-real-time-hcp-targeting

Complex Cohort Identification Fuels Real-Time HCP Targeting

Learn how MMIT, powered by NorstellaLinQ, helped an oncology manufacturer comb through unstructured clinical notes and surface ten times as many patients as with claims data alone.

Slide 2

RELATED SOLUTIONS

Solutions to Support Your Strategy
rwd-visualizations

RWD Visualizations

MMIT’s RWD Visualizations solution combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.

rwd-insights

RWD Insights

Use Norstella proprietary datasets to evaluate key business questions and objectives, conduct deeper data, and create a report with insights layered into each analysis and the overall implications to your strategy.

hcp-patient-targeting

HCP and Patient Targeting

Powered by NorstellaLinQ, MMIT's HCP and Patient Targeting Solution uses structured and unstructured data to pinpoint hard-to-find patients and their treating providers.